Insulin resistance contributes more to the increased risk for diabetes development in subjects with low lipoprotein(a) level than insulin secretion
- PMID: 28510610
- PMCID: PMC5433708
- DOI: 10.1371/journal.pone.0177500
Insulin resistance contributes more to the increased risk for diabetes development in subjects with low lipoprotein(a) level than insulin secretion
Abstract
Background: Recent studies suggest an association between Lipoprotein(a) [Lp(a)] and the development of diabetes mellitus. We analyzed the association between baseline Lp(a) levels and diabetes development after 4 years of follow-up, in a population of apparently healthy Korean subjects.
Methods: A total of 2,536 non-diabetic participants (mean age: 41 years, men: 92%) of a health checkup program were included in the study. Diabetes development was defined by fasting blood glucose ≥126 mg/dL, HbA1c ≥6.5%, and self-reported treatment of diabetes. Homeostasis model assessment (HOMA) indices were used to assess insulin resistance (IR) and insulin secretion (IS). Presence of IR and impaired IS was defined by being in the highest quartile of HOMA-IR and in the lowest quartile HOMA-IS.
Results: After four years, 3.4% of the participants developed diabetes. The odds ratio (OR) of developing diabetes was lowest in the 4th quartile group of baseline Lp(a) (0.323 [95% CI 0.153-0.685])with the 1st quartile group as the reference. The subjects with both IR & impaired IS plus baseline Lp(a)<50 mg/dL showed the higher OR for diabetes development compared with those without IR and normal IS as the reference (67.277 [20.218-223.871], and those with IR plus Lp(a)<50 mg/dL showed higher OR for diabetes than in those with impaired IS and Lp(a)<50 mg/dL (3.811 [1.938-7.495] vs. 3.452 [1.620-7.353]).
Conclusions: The subjects with low baseline Lp(a) level showed higher risk for development of diabetes compared with high baseline Lp(a) level, and this was prominent in those with IR than in those with impaired IS.
Conflict of interest statement
Figures

Similar articles
-
High levels of lipoprotein(a) are associated with a lower prevalence of diabetes with advancing age: results of a cross-sectional epidemiological survey in Gran Canaria, Spain.Cardiovasc Diabetol. 2012 Jul 2;11:81. doi: 10.1186/1475-2840-11-81. Cardiovasc Diabetol. 2012. PMID: 22748161 Free PMC article.
-
Increased risk for development of coronary artery calcification in insulin-resistant subjects who developed diabetes: 4-year longitudinal study.Atherosclerosis. 2016 Feb;245:132-8. doi: 10.1016/j.atherosclerosis.2015.12.010. Epub 2015 Dec 11. Atherosclerosis. 2016. PMID: 26724523
-
Increased risk of coronary artery calcification progression in subjects with high baseline Lp(a) levels: The Kangbuk Samsung Health Study.Int J Cardiol. 2016 Nov 1;222:233-237. doi: 10.1016/j.ijcard.2016.07.219. Epub 2016 Jul 31. Int J Cardiol. 2016. PMID: 27497100
-
Hyperinsulinemia and homeostasis model assessment of insulin resistance as predictors of hypertension: a 5-year follow-up study of Korean sample.Am J Hypertens. 2011 Sep;24(9):1041-5. doi: 10.1038/ajh.2011.89. Epub 2011 May 26. Am J Hypertens. 2011. PMID: 21614095
-
Serum lipoprotein(a) levels and insulin resistance have opposite effects on fatty liver disease.Atherosclerosis. 2020 Sep;308:1-5. doi: 10.1016/j.atherosclerosis.2020.07.020. Epub 2020 Jul 30. Atherosclerosis. 2020. PMID: 32771802
Cited by
-
Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial.Diabetes Care. 2025 Apr 1;48(4):596-604. doi: 10.2337/dc24-2110. Diabetes Care. 2025. PMID: 39913634 Free PMC article. Clinical Trial.
-
Lipoprotein(a) Change After Sleeve Gastrectomy Is Affected by the Presence of Metabolic Syndrome.Obes Surg. 2020 Feb;30(2):545-552. doi: 10.1007/s11695-019-04212-9. Obes Surg. 2020. PMID: 31625055
-
High lipoprotein(a) concentrations are associated with lower type 2 diabetes risk in the Chinese Han population: a large retrospective cohort study.Lipids Health Dis. 2021 Jul 27;20(1):76. doi: 10.1186/s12944-021-01504-x. Lipids Health Dis. 2021. PMID: 34315495 Free PMC article.
References
-
- Berg K (1963) A new serum type system in man—the lp system. Acta Pathol Microbiol Scand 59:369–382. - PubMed
-
- Emerging Risk Factors Collaboration., Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, et al. (2009) Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 302:412–423. doi: 10.1001/jama.2009.1063 - DOI - PMC - PubMed
-
- Nielsen LB, Grønholdt ML, Schroeder TV, Stender S, Nordestgaard BG (1997) In vivo transfer of lipoprotein(a) into human atherosclerotic carotid arterial intima. Arterioscler Thromb Vasc Biol 17: 905–911. - PubMed
-
- Boffa MB, Marcovina SM, Koschinsky ML (2004) Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models. Clin Biochem 37:333–343. doi: 10.1016/j.clinbiochem.2003.12.007 - DOI - PubMed
-
- Bonfleur ML, Vanzela EC, Ribeiro RA, de Gabriel Dorighello G, de França Carvalho CP, Collares-Buzato CB, et al. (2010) Primary hypercholesterolaemia impairs glucose homeostasis and insulin secretion in low-density lipoprotein receptor knockout mice independently of high-fat diet and obesity. Biochim Biophys Acta 1801:183–190. doi: 10.1016/j.bbalip.2009.10.012 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous